Labeler
Alexion Pharmaceuticals Inc. NDC Codes
Alexion Pharmaceuticals Inc. lists 10 finished drug products in the FDA NDC Directory under NDC labeler code 25682.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Active ingredients
- Asfotase alfa, Ravulizumab, Danicopan, Eculizumab
- NDC labeler codes
- 25682
- Strengths
- Danicopan 100 mg/1; Ravulizumab 300 mg/3mL; Ravulizumab 1100 mg/11mL; Ravulizumab 300 mg/30mL; Asfotase alfa 18 mg/.45mL; Asfotase alfa 28 mg/.7mL; Asfotase alfa 40 mg/mL; Asfotase alfa 80 mg/.8mL; Eculizumab 300 mg/30mL
- Dosage forms
- Solution, Solution, Concentrate, Tablet, Film coated, Kit, Injection, Solution, Concentrate
- Routes
- Intravenous, Subcutaneous, Oral
- Drug classes (FDA established)
- Complement Inhibitor, Tissue-nonspecific Alkaline Phosphatase, Complement Factor D Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 10
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Voydeyadanicopan | Danicopan 100 mg/1 | Tablet, Film coatedOral | 25682-043 | 25682-0043-92 | — |
| Voydeyadanicopan | — | Kit | 25682-046 | 25682-0046-92 | — |
| Ultomirisravulizumab | Ravulizumab 300 mg/3mL | Solution, ConcentrateIntravenous | 25682-025 | 25682-0025-01 | — |
| Ultomirisravulizumab | Ravulizumab 1100 mg/11mL | Solution, ConcentrateIntravenous | 25682-028 | 25682-0028-01 | — |
| Ultomirisravulizumab | Ravulizumab 300 mg/30mL | Solution, ConcentrateIntravenous | 25682-022 | 25682-0022-01 | — |
| Strensiqasfotase alfa | Asfotase alfa 18 mg/.45mL | SolutionSubcutaneous | 25682-010 | 25682-0010-12 | — |
| Strensiqasfotase alfa | Asfotase alfa 28 mg/.7mL | SolutionSubcutaneous | 25682-013 | 25682-0013-12 | — |
| Strensiqasfotase alfa | Asfotase alfa 40 mg/mL | SolutionSubcutaneous | 25682-016 | 25682-0016-12 | — |
| Strensiqasfotase alfa | Asfotase alfa 80 mg/.8mL | SolutionSubcutaneous | 25682-019 | 25682-0019-12 | — |
| Soliriseculizumab | Eculizumab 300 mg/30mL | Injection, Solution, ConcentrateIntravenous | 25682-001 | 25682-0001-01 | — |
Alexion Pharmaceuticals Inc.: common questions
- What is Alexion Pharmaceuticals Inc.'s NDC labeler code?
- 25682. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Alexion Pharmaceuticals Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.